In contrast, suPAR and (TIMP-2) × (IGFBP7) as well as urine creatinine, albuminuria, α1-microglobulin did not allow meaningfull and early identification of patients at risk for AKI II/III (Table 2). This evidence concerns the gene TIMP2 and acute kidney injury.